Portfolio company
Mammoth
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops CRISPR-based molecular diagnostics and gene-editing therapies for pharmaceutical partners and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mammoth Biosciences
This biotechnology company develops ultracompact CRISPR-based gene editing therapies and diagnostic tools for pharmaceutical partners and healthcare providers.
Sherlock Biosciences
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
VedaBio
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
Algen Biotechnologies
This company develops a CRISPR and artificial intelligence platform to discover drugs for pharmaceutical partners and its own therapeutic pipeline.
TMA Precision Health
This company provides a clinical decision support platform using genomic data and medical records to improve rare disease diagnosis for health systems and pharmaceutical partners.
Cassidy Bio
This company develops an AI foundation model to design gene editing therapies and prediction tools for pharmaceutical partners and researchers.
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
